Torrent Buy Of Elder Pharma Formulations Business Clears India's CCI
This article was originally published in PharmAsia News
Executive Summary
Torrent Pharma's $333.5 million purchase of the formulations business of Elder Pharma has received the approval of the Competition Commission of India, which considers antitrust issues.
Torrent Pharma's $333.5 million purchase of the formulations business of Elder Pharma has received the approval of the Competition Commission of India, which considers antitrust issues. The deal is confined to Elder's business in India and Nepal. The CCI said it was swayed in part by the fact the two companies together would not have a significant share of the therapeutics market. (Click here for more)
"CCI Clears Torrent-Elder Pharma Deal" - Times Of India (4/10/2014)